LOVFF (Cannara Biotech) Total Equity: $88.08 Mil (As of Feb. 2026)


LOVFF Cannara Biotech Inc LOVFF
83 GF Score
Price $1.21
GF Value $1.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cannara Biotech Total Equity?

Cannara Biotech LOVFF +5.52% 83 Total Equity is $88.08 Mil as of Feb. 2026. GuruFocus rates LOVFF with a GF Score™ of 83/100 and a GF Value™ of $1.15 (Fairly Valued). The stock has 4 warning signs investors should review.

Cannara Biotech's total equity for the quarter that ended in Feb. 2026 was $88.08 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cannara Biotech Total Equity Historical Data

* Premium members only.

The historical data trend for Cannara Biotech's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannara Biotech Total Equity Chart

Cannara Biotech Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Total Equity
Get a 7-Day Free Trial 50.89 51.67 59.17 64.41 74.09

Cannara Biotech Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.87 71.10 74.09 79.12 88.08
LOVFF
83GF Score
Cannara Biotech Inc LOVFF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cannara Biotech Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cannara Biotech's Total Equity for the fiscal year that ended in Aug. 2025 is calculated as

Total Equity=Total Assets(Q: Aug. 2025 )-Total Liabilities(Q: Aug. 2025 )
=122.234-48.145
=74.09

Cannara Biotech's Total Equity for the quarter that ended in Feb. 2026 is calculated as

Total Equity=Total Assets(Q: Feb. 2026 )-Total Liabilities(Q: Feb. 2026 )
=133.212-45.134
=88.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $88.08 Mil mean?
Cannara Biotech (LOVFF) has a Total Equity of $88.08 Mil as of Feb. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Cannara Biotech and its competitors.
Is Cannara Biotech's Total Equity too high?
Cannara Biotech's current Total Equity is $88.08 Mil. Overall, Cannara Biotech has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cannara Biotech's Total Equity compare to ZTS and UTHR?
Cannara Biotech's Total Equity of $88.08 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Cannara Biotech and its competitors. Cannara Biotech's current Total Equity is $88.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannara Biotech stock overvalued right now?
Based on GuruFocus' analysis, Cannara Biotech (LOVFF) is currently considered Fairly Valued. The stock's GF Value™ is $1.15, compared to a current price of $1.21 — trading 5.5% above its estimated fair value. The current Total Equity is $88.08 Mil. Cannara Biotech's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Cannara Biotech (LOVFF), the current Total Equity is $88.08 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cannara Biotech (LOVFF) Overvalued in 2026?

Based on GuruFocus' analysis, Cannara Biotech stock appears to be overvalued. The current stock price of $1.21 is trading 5.5% above its estimated GF Value™ of $1.15. GuruFocus considers Cannara Biotech to be Fairly Valued.

Key valuation signals for LOVFF:

  • Total Equity: $88.08 Mil
  • GF Value™: $1.15 vs. price of $1.21 (5.5% above fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the LOVFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannara Biotech Business Description

Other Exchanges 8CB0:GermanyLOVE:Canada
Address 1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
83GF Score

Get the complete analysis for LOVFF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.21
Price
$1.15
GF Value